These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25822339)

  • 21. Detection of MDM2/CDK4 amplification in lipomatous soft tissue tumors from formalin-fixed, paraffin-embedded tissue: comparison of multiplex ligation-dependent probe amplification (MLPA) and fluorescence in situ hybridization (FISH).
    Creytens D; van Gorp J; Ferdinande L; Speel EJ; Libbrecht L
    Appl Immunohistochem Mol Morphol; 2015 Feb; 23(2):126-33. PubMed ID: 25679065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MDM2+/CDK4+/p53+ oral liposarcoma: case report and review of the literature.
    Nikitakis NG; Lopes MA; Pazoki AE; Ord RA; Sauk JJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):194-201. PubMed ID: 11505267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Could changes in the regulation of the PI3K/PKB/Akt signaling pathway and cell cycle be involved in astrocytic tumor pathogenesis and progression?
    Hlobilkova A; Ehrmann J; Sedlakova E; Krejci V; Knizetova P; Fiuraskova M; Kala M; Kalita O; Kolar Z
    Neoplasma; 2007; 54(4):334-41. PubMed ID: 17822324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of PSMD10, CDK4, and Tumor Suppressors in Development of Intrahepatic Cholangiocarcinoma of Syrian Golden Hamsters Induced by Clonorchis sinensis and N-Nitrosodimethylamine.
    Uddin MH; Choi MH; Kim WH; Jang JJ; Hong ST
    PLoS Negl Trop Dis; 2015; 9(8):e0004008. PubMed ID: 26313366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway.
    Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH
    Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR.
    Sirvent N; Coindre JM; Maire G; Hostein I; Keslair F; Guillou L; Ranchere-Vince D; Terrier P; Pedeutour F
    Am J Surg Pathol; 2007 Oct; 31(10):1476-89. PubMed ID: 17895748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrated molecular characterization of adult soft tissue sarcoma for therapeutic targets.
    Kim J; Kim JH; Kang HG; Park SY; Yu JY; Lee EY; Oh SE; Kim YH; Yun T; Park C; Cho SY; You HJ
    BMC Med Genet; 2018 Dec; 19(Suppl 1):216. PubMed ID: 30598078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The tumor suppressor PTEN interacts with p53 in hereditary cancer (Review).
    Nakanishi A; Kitagishi Y; Ogura Y; Matsuda S
    Int J Oncol; 2014 Jun; 44(6):1813-9. PubMed ID: 24718924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Most malignant fibrous histiocytomas developed in the retroperitoneum are dedifferentiated liposarcomas: a review of 25 cases initially diagnosed as malignant fibrous histiocytoma.
    Coindre JM; Mariani O; Chibon F; Mairal A; De Saint Aubain Somerhausen N; Favre-Guillevin E; Bui NB; Stoeckle E; Hostein I; Aurias A
    Mod Pathol; 2003 Mar; 16(3):256-62. PubMed ID: 12640106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Temperature Sensitive Variant of p53 Drives p53-Dependent MicroRNA Expression without Evidence of Widespread Post-Transcriptional Gene Silencing.
    Cabrita MA; Vanzyl EJ; Hamill JD; Pan E; Marcellus KA; Tolls VJ; Alonzi RC; Pastic A; Rambo TM; Sayed H; McKay BC
    PLoS One; 2016; 11(2):e0148529. PubMed ID: 26840126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p53+/mdm2- atypical lipomatous tumor/well-differentiated liposarcoma in young children: an early expression of Li-Fraumeni syndrome.
    Debelenko LV; Perez-Atayde AR; Dubois SG; Grier HE; Pai SY; Shamberger RC; Kozakewich HP
    Pediatr Dev Pathol; 2010; 13(3):218-24. PubMed ID: 20028212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoreactivity of p53, mdm2, and p21WAF1 in dedifferentiated liposarcoma: special emphasis on the distinct immunophenotype of the well-differentiated component.
    Adachi T; Oda Y; Sakamoto A; Saito T; Tamiya S; Masuda K; Tsuneyoshi M
    Int J Surg Pathol; 2001 Apr; 9(2):99-109. PubMed ID: 11484509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the 12q amplicons in lipomatous soft tissue tumors by multiplex ligation-dependent probe amplification-based copy number analysis.
    Creytens D; Van Gorp J; Speel EJ; Ferdinande L
    Anticancer Res; 2015 Apr; 35(4):1835-42. PubMed ID: 25862836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deregulation of dicer and mir-155 expression in liposarcoma.
    Vincenzi B; Iuliani M; Zoccoli A; Pantano F; Fioramonti M; De Lisi D; Frezza AM; Rabitti C; Perrone G; Onetti Muda A; Russo A; Giordano A; Santini D; Dei Tos AP; Tonini G
    Oncotarget; 2015 Apr; 6(12):10586-91. PubMed ID: 25888631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of germline and tumor mutations of p53 gene in familial occurrence of soft tissue sarcomas.
    Kudawara I; Matsumine A; Ohzono K
    J Surg Oncol; 2007 Mar; 95(4):347-50. PubMed ID: 17192950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. G protein pathway suppressor 2 (GPS2) acts as a tumor suppressor in liposarcoma.
    Huang XD; Xiao FJ; Wang SX; Yin RH; Lu CR; Li QF; Liu N; Zhang Y; Wang LS; Li PY
    Tumour Biol; 2016 Oct; 37(10):13333-13343. PubMed ID: 27460081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA expression profiles distinguish liposarcoma subtypes and implicate miR-145 and miR-451 as tumor suppressors.
    Gits CM; van Kuijk PF; Jonkers MB; Boersma AW; Smid M; van Ijcken WF; Coindre JM; Chibon F; Verhoef C; Mathijssen RH; den Bakker MA; Verweij J; Sleijfer S; Wiemer EA
    Int J Cancer; 2014 Jul; 135(2):348-61. PubMed ID: 24375455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular abnormalities in liposarcoma: role of MDM2 and CDK4-containing amplicons at 12q13-22.
    Pilotti S; Della Torre G; Lavarino C; Sozzi G; Minoletti F; Vergani B; Azzarelli A; Rilke F; Pierotti MA
    J Pathol; 1998 Jun; 185(2):188-90. PubMed ID: 9713346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene expression profiling of liposarcoma identifies distinct biological types/subtypes and potential therapeutic targets in well-differentiated and dedifferentiated liposarcoma.
    Singer S; Socci ND; Ambrosini G; Sambol E; Decarolis P; Wu Y; O'Connor R; Maki R; Viale A; Sander C; Schwartz GK; Antonescu CR
    Cancer Res; 2007 Jul; 67(14):6626-36. PubMed ID: 17638873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation.
    Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; DePinho RA
    Nature; 2008 Oct; 455(7216):1129-33. PubMed ID: 18948956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.